Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: A multivariate meta-analysis.
<h4>Aims</h4>To explore the effect of glucagon-like peptide-1 receptor agonist (GLP-1 RAs) on glycemic control and weight reduction in adults.<h4>Methods</h4>Databases were searched from August 2021 to March 2022. Data were analyzed using mean difference (MD) values with 95%...
Main Authors: | Tzu-Lin Yeh, Ming-Chieh Tsai, Wen-Hsuan Tsai, Yu-Kang Tu, Kuo-Liong Chien |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0278685 |
Similar Items
-
Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
by: Magda Wojtara, et al.
Published: (2023-01-01) -
Relationship between Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes
by: Jun-Jun Yeh, et al.
Published: (2024-02-01) -
Glucagon‐like peptide agonists: A prospective review
by: Zamara Mariam, et al.
Published: (2024-01-01) -
The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease
by: Yuan Lin, et al.
Published: (2023-03-01) -
Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)